Amalgamated Bank’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
AAA
VCM
PAI
6CM
Amalgamated Bank's ANAB Position: Q1 2026 in Review
Amalgamated Bank sold out of AnaptysBio (ANAB) in Q1 2026, closing a stake of 580 shares — an estimated $28K sold.
Amalgamated Bank first reported a position in ANAB in Q4 2017 and held it in 21 quarters. The position peaked at $249K in Q1 2018. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.
- Amalgamated Bank reported no remaining AnaptysBio position as of Q1 2026 after selling out during the quarter.
- Amalgamated Bank sold 580 AnaptysBio shares in Q1 2026, an estimated $28K.
- Amalgamated Bank first reported a position in AnaptysBio in Q4 2017 and held it in 21 quarters.
- Amalgamated Bank's AnaptysBio position peaked at $249K in Q1 2018.
- 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.
Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.